Bellevue Group AG Raises Stock Position in Axsome Therapeuti

Bellevue Group AG increased its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 0.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 635,372 shares of the company’s stock after purchasing an additional 3,885 shares during the quarter. Bellevue Group AG owned 1.34% […]

Related Keywords

United States , Canada , Markl Jacobson , Mark Coleman , Robertw Baird , Wealth Group , Affinity Asset Advisors , Royal Bank , Citigroup , Axsome Therapeutics Inc , Exchange Commission , Td Asset Management Inc , Bellevue Group , Lighthouse Investment Partners , Nasdaq , Securities Exchange Commission , Axsome Therapeutics , Free Report , Investment Partners , Asset Advisors , Partners Asset Management , Management Inc , Director Mark Coleman , Therapeutics Trading Down , Get Free Report , Axsome Therapeutics Daily ,